2. Natural Products
  3. Plants
  4. Taxodiaceae

Taxodiaceae

 

Taxodiaceae (5):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-W009417
    Cedryl acetate 77-54-3 99.78%
    Cedryl acetate is an orally active α-glucosidase inhibitor with an IC50 of 94 μM against yeast α-glucosidase. Cedryl acetate reduces high-fat diet-induced body weight gain, visceral fat pad weight, adipocyte hypertrophy, hepatic lipid accumulation, glucose intolerance, insulin resistance and gluconeogenesis. Cedryl acetate can be used in the research of obesity and obesity-related metabolic syndrome.
    Cedryl acetate
  • HY-N10871
    Neocryptomerin 20931-36-6 99.14%
    Neocryptomerin, a biflavonoid, shows inhibitory activity against U251, MCF-7, HeLa cell. Neocryptomerin has favorable binding affinities in the active pocket of SARS-CoV-2. Neocryptomerin is the leading compound of rational compounds against COVID-19.
    Neocryptomerin
  • HY-N16906
    13-Hydroxylabda-8(17),14-dien-18-oic acid 83915-59-7
    13-Hydroxylabda-8(17),14-dien-18-oic acid is a natural diterpene.
    13-Hydroxylabda-8(17),14-dien-18-oic acid
  • HY-N16540
    4-Deoxyphlorizin 31018-48-1
    4-Deoxyphlorizin is a xyloglucan endotransglucosylase (XET) enhancer. 4-Deoxyphlorizin can enhance the XET-catalyzed transglycosylation reaction.
    4-Deoxyphlorizin
  • HY-W009417R
    Cedryl acetate (Standard) 77-54-3
    Cedryl acetate (Standard) is the analytical standard of Cedryl acetate. This product is intended for research and analytical applications. Cedryl acetate is an orally active α-glucosidase inhibitor with an IC50 of 94 μM against yeast α-glucosidase. Cedryl acetate reduces high-fat diet-induced body weight gain, visceral fat pad weight, adipocyte hypertrophy, hepatic lipid accumulation, glucose intolerance, insulin resistance and gluconeogenesis. Cedryl acetate can be used in the research of obesity and obesity-related metabolic syndrome.
    Cedryl acetate (Standard)